ArticlePharmaceutics2023

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

Giovanni Canil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.